Evsyutina Y, Komkova I, Zolnikova O, Tkachenko P, Ivashkin V. Lung microbiome in healthy and diseased individuals. World J Respirol 2017; 7(2): 39-47 [DOI: 10.5320/wjr.v7.i2.39]
Corresponding Author of This Article
Inna Komkova, PhD, Department of Pulmonology, First Moscow State Medical University, Trubetskaya Str., Bld. 8/2, Moscow 119991, Russia. drkomkova@gmail.com
Research Domain of This Article
Respiratory System
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Respirol. Jul 28, 2017; 7(2): 39-47 Published online Jul 28, 2017. doi: 10.5320/wjr.v7.i2.39
Lung microbiome in healthy and diseased individuals
Yulia Evsyutina, Inna Komkova, Oksana Zolnikova, Petr Tkachenko, Vladimir Ivashkin
Yulia Evsyutina, Department of Gastroenterology, First Moscow State Medical University, Moscow 119991, Russia
Inna Komkova, Oksana Zolnikova, Department of Pulmonology, First Moscow State Medical University, Moscow 119991, Russia
Petr Tkachenko, Department of Hepatology, First Moscow State Medical University, Moscow 119991, Russia
Vladimir Ivashkin, Director of University Clinical Hospital 2, First Moscow State Medical University, Moscow 119991, Russia
Author contributions: All authors contributed to this paper with the conception, literature review and analysis; Evsyutina Y, Komkova I and Zolnikova O wrote the manuscript; Tkachenko P and Ivashkin V reviewed and edited the manuscript critically; all authors approved the final version.
Conflict-of-interest statement: All the authors have no conflicts of interests to declare.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Inna Komkova, PhD, Department of Pulmonology, First Moscow State Medical University, Trubetskaya Str., Bld. 8/2, Moscow 119991, Russia. drkomkova@gmail.com
Telephone: +7-926-7166875
Received: October 30, 2016 Peer-review started: November 3, 2016 First decision: February 16, 2017 Revised: March 15, 2017 Accepted: April 16, 2017 Article in press: April 17, 2017 Published online: July 28, 2017 Processing time: 263 Days and 8.1 Hours
Abstract
The data on quantitative and qualitative microbial composition of the respiratory tract of healthy individuals revealed significant differences when compared with the microbiota of patients suffering from respiratory diseases. Possible etiological role of microbiota in pulmonary diseases as well as drug resistance development is of profound interest nowadays. Numerous studies have provided evidence confirming the relationship between gut microbiome and those of lungs. This relationship could explain how changes in the microbial communities in one organ may lead to pathological changes in the other. Till date, some progress has been made in the study of the biological properties of probiotic bacteria, considering their modulating effect on inflammatory immune response. The use of probiotics which exhibits an immunomodulatory potential looks promising.
Core tip: The role of the respiratory tract microbiota in a healthy state and in respiratory diseases is broadly discussed nowadays. There is also a big amount of data regarding contribution of gastrointestinal microbiota changes in respiratory diseases development. A gut-lung axis conception is of great interest. Perspective of prebiotics and probiotics application in lung diseases treatment looks very promising. Huge number of researches has been done on topics mentioned above. Our objective is to consolidate the current literature to summarize the most recent and most important data concerning this subject.
